Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Michael McDermott

Concepts (149)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Hyperthyroidism
5
2020
26
1.750
Why?
Hypothyroidism
5
2020
64
1.670
Why?
Graves Disease
2
2020
32
0.770
Why?
Osteoporosis
5
2009
226
0.750
Why?
Triiodothyronine
3
2020
42
0.730
Why?
Thyroid Neoplasms
2
2020
264
0.730
Why?
Thyroxine
3
2020
56
0.660
Why?
Bone Density Conservation Agents
2
2009
62
0.590
Why?
Thyroid Diseases
4
2005
30
0.580
Why?
Hypoglycemic Agents
2
2016
1013
0.560
Why?
Thyrotoxicosis
2
2020
8
0.550
Why?
Vitamins
2
2008
151
0.530
Why?
Vitamin D
3
2008
341
0.520
Why?
Antithyroid Agents
4
2020
11
0.510
Why?
Iodine Radioisotopes
4
2020
125
0.490
Why?
Dipeptidyl-Peptidase IV Inhibitors
1
2012
44
0.390
Why?
Thyrotropin
4
2020
99
0.380
Why?
Vitamin D Deficiency
3
2009
158
0.380
Why?
Diabetes Mellitus, Type 2
2
2016
2096
0.370
Why?
Diagnosis, Differential
4
2020
1342
0.360
Why?
Premenopause
1
2009
106
0.310
Why?
Patient Education as Topic
2
2015
680
0.310
Why?
Thyroidectomy
2
2020
53
0.270
Why?
Thyroid Hormones
2
2020
53
0.260
Why?
Endocrinology
2
2004
70
0.260
Why?
Pharmacists
1
2008
234
0.260
Why?
Cardiovascular Diseases
1
2016
1727
0.250
Why?
Hormone Replacement Therapy
2
2020
77
0.250
Why?
Bone Density
4
2009
432
0.240
Why?
Hospitalization
2
2020
1752
0.240
Why?
Humans
28
2020
114705
0.230
Why?
Reproductive Medicine
1
2004
15
0.220
Why?
Professional Practice
1
2003
62
0.220
Why?
Blood Glucose
2
2016
1828
0.210
Why?
Thyrotropin, beta Subunit
1
2002
5
0.210
Why?
Insulin
2
2016
2080
0.200
Why?
Drug Therapy, Combination
2
2020
951
0.200
Why?
Diabetes Mellitus
2
2008
900
0.200
Why?
Point Mutation
1
2002
216
0.190
Why?
Hip Fractures
1
2003
75
0.190
Why?
Thyroid Gland
1
2002
82
0.190
Why?
Methimazole
1
2020
6
0.180
Why?
Myxedema
1
2020
1
0.180
Why?
Absorptiometry, Photon
3
2009
224
0.170
Why?
Mass Screening
3
2020
1006
0.170
Why?
Diet
1
2007
1080
0.170
Why?
Risk Factors
5
2020
8632
0.170
Why?
Treatment Failure
1
2020
331
0.170
Why?
Female
16
2020
59521
0.160
Why?
Physical Examination
1
2020
222
0.160
Why?
Practice Guidelines as Topic
2
2020
1395
0.160
Why?
Reference Values
1
2020
743
0.160
Why?
Triiodothyronine, Reverse
1
2018
2
0.150
Why?
Practice Patterns, Physicians'
2
2006
1177
0.150
Why?
Thyroid Function Tests
1
2018
11
0.150
Why?
Adrenergic beta-Antagonists
1
2020
287
0.150
Why?
Hypoglycemia
2
2016
387
0.140
Why?
Parathyroid Hormone
2
2008
96
0.140
Why?
Biomarkers
2
2020
3408
0.140
Why?
Pregnancy Complications
1
2020
429
0.130
Why?
Referral and Consultation
1
2020
635
0.130
Why?
Insulin Antibodies
1
2016
102
0.120
Why?
Neoplasm Recurrence, Local
1
2020
859
0.120
Why?
Rituximab
1
2016
150
0.120
Why?
Aged
9
2016
19074
0.110
Why?
Ambulatory Care
2
2008
478
0.110
Why?
Immunologic Factors
1
2016
220
0.110
Why?
Pregnancy
3
2020
5520
0.110
Why?
Case-Control Studies
1
2020
3003
0.110
Why?
Sex Factors
2
2012
1715
0.110
Why?
Diabetes Complications
1
2015
211
0.110
Why?
Age Factors
2
2012
2894
0.100
Why?
Autoimmune Diseases
1
2016
382
0.100
Why?
Aged, 80 and over
3
2008
6347
0.100
Why?
Thyroid Crisis
1
2012
7
0.100
Why?
Retrospective Studies
3
2020
12556
0.100
Why?
Postpartum Thyroiditis
1
2011
1
0.100
Why?
Non-alcoholic Fatty Liver Disease
1
2015
245
0.100
Why?
Structure-Activity Relationship
1
2012
502
0.090
Why?
Drug Interactions
1
2012
338
0.090
Why?
Liver Diseases
1
2012
255
0.080
Why?
Risk
1
2012
812
0.080
Why?
Colorado
4
2009
4100
0.080
Why?
Male
10
2016
55607
0.080
Why?
Adipokines
1
2009
42
0.080
Why?
Obesity
2
2015
2508
0.080
Why?
Kidney Diseases
1
2012
350
0.080
Why?
Community-Institutional Relations
1
2009
89
0.080
Why?
Raloxifene Hydrochloride
1
2008
13
0.070
Why?
Patient Care
1
2008
101
0.070
Why?
Self Administration
1
2008
122
0.070
Why?
Diphosphonates
1
2008
51
0.070
Why?
Pilot Projects
2
2009
1373
0.070
Why?
Pharmaceutical Services
1
2008
77
0.070
Why?
Professional Role
1
2008
149
0.070
Why?
Women's Health
1
2009
271
0.070
Why?
Life Style
1
2009
430
0.070
Why?
Nutrition Policy
1
2007
54
0.070
Why?
Health Knowledge, Attitudes, Practice
1
2015
1183
0.070
Why?
Phosphorus
1
2007
82
0.070
Why?
Insulin Lispro
1
2006
35
0.070
Why?
Nonprescription Drugs
1
2007
68
0.070
Why?
Serum Albumin
1
2007
137
0.070
Why?
Body Composition
1
2009
590
0.060
Why?
Creatinine
1
2007
425
0.060
Why?
Quality of Health Care
1
2009
573
0.060
Why?
Patient Compliance
1
2008
525
0.060
Why?
Middle Aged
6
2015
26738
0.060
Why?
Fractures, Bone
1
2009
367
0.060
Why?
Outpatients
1
2007
326
0.060
Why?
Thyroid Nodule
1
2003
39
0.050
Why?
Densitometry
1
2003
29
0.050
Why?
Inpatients
1
2006
380
0.050
Why?
Hospitals, University
1
2003
172
0.050
Why?
Health Services for the Aged
1
2003
70
0.050
Why?
Medical Records
1
2003
153
0.050
Why?
Pulmonary Disease, Chronic Obstructive
1
2009
916
0.050
Why?
Exons
1
2002
302
0.050
Why?
Biopsy, Needle
1
2002
182
0.050
Why?
Calcium
1
2007
1108
0.050
Why?
Prevalence
1
2007
2251
0.050
Why?
Cross-Sectional Studies
2
2009
4410
0.040
Why?
Adenoma
1
2002
189
0.040
Why?
Follow-Up Studies
1
2008
4411
0.040
Why?
Base Sequence
1
2002
2114
0.040
Why?
Amino Acid Sequence
1
2002
1982
0.040
Why?
Exercise
1
2009
1644
0.040
Why?
Surveys and Questionnaires
2
2015
4624
0.040
Why?
Molecular Sequence Data
1
2002
2785
0.040
Why?
Risk Assessment
1
2006
2968
0.040
Why?
Patient Discharge
1
2003
773
0.030
Why?
Biomarkers, Tumor
1
2002
1040
0.030
Why?
Prospective Studies
1
2007
6220
0.030
Why?
Blood Glucose Self-Monitoring
1
2016
505
0.020
Why?
Adult
3
2015
30553
0.020
Why?
Severity of Illness Index
2
2009
2540
0.020
Why?
Resistin
1
2009
12
0.020
Why?
Biological Factors
1
2009
35
0.020
Why?
Medical Audit
1
2008
75
0.020
Why?
Hip Joint
1
2009
126
0.020
Why?
Leptin
1
2009
210
0.020
Why?
Adiponectin
1
2009
213
0.020
Why?
Lumbar Vertebrae
1
2009
210
0.020
Why?
Body Mass Index
1
2015
1959
0.020
Why?
Insulin Resistance
1
2015
1072
0.020
Why?
Program Evaluation
1
2008
822
0.010
Why?
Tumor Necrosis Factor-alpha
1
2009
1140
0.010
Why?
Treatment Outcome
1
2016
9088
0.010
Why?
Lung
1
2009
3561
0.010
Why?
McDermott's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)